Eads & Heald Wealth Management Abb Vie Inc. Transaction History

Eads & Heald Wealth Management

$211 Million
Q3 2024

A detailed history of Eads & Heald Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Eads & Heald Wealth Management holds 11,103 shares of ABBV stock, worth $1.83 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

11,103

Previous 12,154 8.65%

Holding current value

$1.83 Million

Previous $2.08 Million 5.23%

% of portfolio

1.04%

Previous 1.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $172,195 - $209,495	-1,051 Reduced 8.65%	11,103 $2.19 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $61,296 - $71,580	-396 Reduced 3.16%	12,154 $2.08 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $225,985 - $257,489	-1,414 Reduced 10.13%	12,550 $2.29 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $2,201 - $2,479	-16 Reduced 0.11%	13,964 $2.16 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $52,100 - $60,313	-390 Reduced 2.71%	13,980 $2.08 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $66,652 - $82,944	-503 Reduced 3.38%	14,370 $1.94 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $24,149 - $27,812	-167 Reduced 1.11%	14,873 $2.37 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $2,904 - $3,483	-21 Reduced 0.14%	15,040 $2.43 Million
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $93,812 - $107,597	699 Added 4.87%	15,061 $2.02 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $35,505 - $45,139	-258 Reduced 1.76%	14,362 $2.2 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $42,101 - $52,236	-319 Reduced 2.14%	14,620 $2.37 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $27,502 - $34,798	256 Added 1.74%	14,939 $2.02 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $208,331 - $236,487	1,958 Added 15.39%	14,683 $1.58 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $733,944 - $817,656	6,976 Added 121.34%	12,725 $1.43 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $11,253 - $12,388	110 Added 1.95%	5,749 $622,000
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $7,002 - $9,454	87 Added 1.57%	5,639 $604,000
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $178,263 - $209,222	2,075 Added 59.68%	5,552 $486,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $255,107 - $341,371	3,477 New	3,477 $341,000
Q1 2020 May 01, 2020	SELL	$64.5 - $97.79 $192,081 - $291,218	-2,978 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $2,524 - $3,158	-35 Reduced 1.16%	2,978 $263,000
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $7,557 - $9,086	-120 Reduced 3.83%	3,013 $228,000
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $3,085 - $3,631	40 Added 1.29%	3,133 $0
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $240,790 - $296,958	3,093 New	3,093 $285,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Account

Eads & Heald Wealth Management Abb Vie Inc. Transaction History